Read More Pharma Industry News Aligos receives $25m Amoytop payment as China HBV catalyst strengthens Aligos receives $25 million from Amoytop as China grants breakthrough status to its HBV drug. Read how the deal reshapes ALGS cash runway and strategy. byVenkateshJuly 8, 2026